Thymus fontanesii attenuates CCl
Animals
Anti-Inflammatory Agents
/ pharmacology
Antioxidants
/ pharmacology
Carbon Tetrachloride
/ adverse effects
Flavonoids
/ metabolism
Inflammation
/ drug therapy
Lipid Peroxidation
/ drug effects
Liver
/ drug effects
Liver Cirrhosis
/ drug therapy
Male
Mice
Molecular Docking Simulation
/ methods
Oxidative Stress
/ drug effects
Phenols
/ metabolism
Plant Extracts
/ pharmacology
Thymus Plant
/ chemistry
Transforming Growth Factor beta1
/ metabolism
Anti-inflammatory
Antioxidant
CCl(4)
TGF-β
Thyme
Thymus fontanesii
Journal
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
20
01
2022
revised:
17
02
2022
accepted:
17
02
2022
pubmed:
25
2
2022
medline:
26
3
2022
entrez:
24
2
2022
Statut:
ppublish
Résumé
Liver injury is a major public health problem all over the world that raises the demand of developing novel effective and safe remedies. Traditionally, Thyme (Thymus fontanesii) has a therapeutic potential against different organs toxicity due to its antioxidant activity. The present study aimed to evaluate the antioxidant activities in vitro and the possible hepato-protective effects of T. fontanesii aqueous extract (TFAE) against CCl
Identifiants
pubmed: 35202909
pii: S0753-3322(22)00126-3
doi: 10.1016/j.biopha.2022.112738
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Antioxidants
0
Flavonoids
0
Phenols
0
Plant Extracts
0
Transforming Growth Factor beta1
0
Carbon Tetrachloride
CL2T97X0V0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112738Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.